RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.-论文-万方医学网

第一作者： Beryl,McCormick

第一单位： Beryl McCormick and Clifford Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; Kathryn Winter and Jennifer Moughan, Radiation Therapy Oncology Group Statistical Center, Philadelphia; Amit Shah, York Cancer Center, York; Albert Yuen, Reading Hospital and Medical Center, Reading, PA; Henry Mark Kuerer, Nour Sneige, and Eric A. Strom, The University of Texas MD Anderson Cancer Center, Houston, TX; Barbara L. Smith, Massachusetts General Hospital, Boston, MA; Alan C. Hartford, Dartmouth Hitchcock Medical Center, Lebanon, NH; Afshin Rashtian, University of Southern California, Los Angeles, Los Angeles; Anthony T. Pu, Radiological Associates of Sacramento, Sacramento, CA; Eleanor M. Walker, Henry Ford Hospital, Detroit, MI; Jeannette L. Wilcox, Greenville SC Community Clinical Oncology Program (CCOP), Greenville, SC; Laura A. Vallow, Mayo Clinic, Jacksonville, FL; William Small Jr, Northwestern University Feinberg School of Medicine, Chicago, IL; Kevin Kerlin, Southeast Cancer Control Consortium CCOP, Winston-Salem, NC; Julia White, James Cancer Hospital, Ohio State University, Columbus, OH; Eileen Rakovitch, Toronto-Sunnybrook Regional Cancer Centre, Toronto, Ontario; and Isabelle Germain, L'Hotel-Dieu de Quebec, Quebec, Quebec, Canada. mccormib@mskcc.org.

作者： Beryl,McCormick ^[1] ; Kathryn,Winter ^[2] ; Clifford,Hudis ^[2] ; Henry Mark,Kuerer ^[2] ; Eileen,Rakovitch ^[2] ; Barbara L,Smith ^[2] ; Nour,Sneige ^[2] ; Jennifer,Moughan ^[2] ; Amit,Shah ^[2] ; Isabelle,Germain ^[2] ; Alan C,Hartford ^[2] ; Afshin,Rashtian ^[2] ; Eleanor M,Walker ^[2] ; Albert,Yuen ^[2] ; Eric A,Strom ^[2] ; Jeannette L,Wilcox ^[2] ; Laura A,Vallow ^[2] ; William,Small ^[2] ; Anthony T,Pu ^[2] ; Kevin,Kerlin ^[2] ; Julia,White ^[2]

作者单位： Beryl McCormick and Clifford Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; Kathryn Winter and Jennifer Moughan, Radiation Therapy Oncology Group Statistical Center, Philadelphia; Amit Shah, York Cancer Center, York; Albert Yuen, Reading Hospital and Medical Center, Reading, PA; Henry Mark Kuerer, Nour Sneige, and Eric A. Strom, The University of Texas MD Anderson Cancer Center, Houston, TX; Barbara L. Smith, Massachusetts General Hospital, Boston, MA; Alan C. Hartford, Dartmouth Hitchcock Medical Center, Lebanon, NH; Afshin Rashtian, University of Southern California, Los Angeles, Los Angeles; Anthony T. Pu, Radiological Associates of Sacramento, Sacramento, CA; Eleanor M. Walker, Henry Ford Hospital, Detroit, MI; Jeannette L. Wilcox, Greenville SC Community Clinical Oncology Program (CCOP), Greenville, SC; Laura A. Vallow, Mayo Clinic, Jacksonville, FL; William Small Jr, Northwestern University Feinberg School of Medicine, Chicago, IL; Kevin Kerlin, Southeast Cancer Control Consortium CCOP, Winston-Salem, NC; Julia White, James Cancer Hospital, Ohio State University, Columbus, OH; Eileen Rakovitch, Toronto-Sunnybrook Regional Cancer Centre, Toronto, Ontario; and Isabelle Germain, L'Hotel-Dieu de Quebec, Quebec, Quebec, Canada. mccormib@mskcc.org. ^[1] Beryl McCormick and Clifford Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; Kathryn Winter and Jennifer Moughan, Radiation Therapy Oncology Group Statistical Center, Philadelphia; Amit Shah, York Cancer Center, York; Albert Yuen, Reading Hospital and Medical Center, Reading, PA; Henry Mark Kuerer, Nour Sneige, and Eric A. Strom, The University of Texas MD Anderson Cancer Center, Houston, TX; Barbara L. Smith, Massachusetts General Hospital, Boston, MA; Alan C. Hartford, Dartmouth Hitchcock Medical Center, Lebanon, NH; Afshin Rashtian, University of Southern California, Los Angeles, Los Angeles; Anthony T. Pu, Radiological Associates of Sacramento, Sacramento, CA; Eleanor M. Walker, Henry Ford Hospital, Detroit, MI; Jeannette L. Wilcox, Greenville SC Community Clinical Oncology Program (CCOP), Greenville, SC; Laura A. Vallow, Mayo Clinic, Jacksonville, FL; William Small Jr, Northwestern University Feinberg School of Medicine, Chicago, IL; Kevin Kerlin, Southeast Cancer Control Consortium CCOP, Winston-Salem, NC; Julia White, James Cancer Hospital, Ohio State University, Columbus, OH; Eileen Rakovitch, Toronto-Sunnybrook Regional Cancer Centre, Toronto, Ontario; and Isabelle Germain, L'Hotel-Dieu de Quebec, Quebec, Quebec, Canada. ^[2]

主题词成年人(Adult);老年人(Aged);乳腺肿瘤(Breast Neoplasms);加拿大(Canada);癌, 导管内, 非浸润性(Carcinoma, Intraductal, Noninfiltrating);疾病管理(Disease Management);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);乳房X线摄影术(Mammography);乳房切除术, 区段(Mastectomy, Segmental);中年人(Middle Aged);肿瘤复发, 局部(Neoplasm Recurrence, Local);比值比(Odds Ratio);前瞻性研究(Prospective Studies);放射疗法, 辅助(Radiotherapy, Adjuvant);危险性评估(Risk Assessment);治疗结果(Treatment Outcome);美国(United States);观察性等待(Watchful Waiting)

DOI 10.1200/JCO.2014.57.9029

PMID 25605856

发布时间 2022-04-08

检索历史清除

RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.

Journal of clinical oncology

相似文献

Journal of clinical oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.

Journal of clinical oncology

相似文献

Journal of clinical oncology

相关期刊

检索历史清除